Article
Published 14 Oct 2025
BIOSECURE Included In Draft National Defense Authorization Act Of 2026
Goodwin Procter LLP
Your search returned 6,472 results
Refine Your Search
Search Results
- Relevance
- Newest
- Oldest
Article
Published 14 Oct 2025
EPO To Allow Color And Greyscale Patent Drawings: What U.S. Companies Need To Know
Barnes & Thornburg LLP
Article
Published 14 Oct 2025
Celltrion Announces Launch Of AVTOZMA® (Tocilizumab-anoh) Intravenous Formulation In The United States
Goodwin Procter LLP
Article
Published 14 Oct 2025
Connecting Innovators In Life Sciences With Jennifer Hawks Bland (Podcast)
Crowley Law LLC
Article
Published 13 Oct 2025
Kashiv BioSciences Omalizumab Biosimilar Application Submitted To FDA, Accepted By EMA
Goodwin Procter LLP
Article
Published 9 Oct 2025
Biogen Ordered To Pay Genentech $88.3 Million In Past Royalties On Cabilly Patents
Goodwin Procter LLP
Article
Published 8 Oct 2025
Aflibercept BPCIA Multi-District Litigation Updates
Goodwin Procter LLP
Article
Published 8 Oct 2025
The Continued Rise Of Royalty Deals In Life Sciences
Goodwin Procter LLP
Article
Published 8 Oct 2025
Key Considerations For Food Safety Recalls
Steptoe LLP
Article
Published 8 Oct 2025
FDA Seeks Stakeholder Feedback On AI-Enabled Medical Device Performance
Katten Muchin Rosenman LLP
Video
Published 8 Oct 2025
Non-binding Guidance: The Administration's Focus On Direct-to-Consumer Prescription Drug Advertising (Podcast)
Ropes & Gray LLP
Article
Published 8 Oct 2025
FDA Seeks Input On Real-World Performance Of AI-Enabled Medical Devices: What Biotech And MedTech Innovators Need To Know
Crowell & Moring LLP
Podcast
Published 7 Oct 2025
Podcast - Part I: Going From Young Associate To Veteran Lawyer
Holland & Knight
Article
Published 7 Oct 2025
FDA Approves Seventh Denosumab Biosimilar: Richter And Hikma's Enoby And Xtrenbo
Goodwin Procter LLP
Article
Published 7 Oct 2025
State Of Capital Markets For Public Companies: A Comprehensive Look At The Technology, Clean Energy, And Life Sciences Sectors In 2025
Foley & Lardner
Article
Published 7 Oct 2025
Healthcare AI In The United States — Navigating Regulatory Evolution, Market Dynamics, And Emerging Challenges In An Era Of Rapid Innovation
Jones Walker
Article
Published 6 Oct 2025
The Trump Administration Continues To Make Drug Pricing Moves, Announces First MFN Agreement
Akin Gump Strauss Hauer & Feld LLP
Article
Published 6 Oct 2025
President Trump's Recent Post Concerning CBD And Potential Implications
Buchanan Ingersoll & Rooney PC
Article
Published 6 Oct 2025
USDA's Spring 2025 Unified Agenda Includes Rules Regarding Biotechnology Products And Bioengineered Foods
Bergeson & Campbell
Article
Published 3 Oct 2025
Life Sciences And Medtech Policy Update: Key Things To Know Q4 2025
Goodwin Procter LLP